Nrf2 Pathway and Oxidative Stress as a Common Target for Treatment of Diabetes and Its Comorbidities

Area of Science:

• Biomedical Science
• Metabolic Disorders
• Oxidative Stress Research

Background:

• Diabetes mellitus is a chronic condition linked to severe comorbidities, including cardiovascular disease, nephropathy, and liver damage.
• Increased oxidative stress is a key mechanism underlying diabetic complications.
• The role of the nuclear factor erythroid 2-related factor 2 (Nrf2) pathway in mediating these effects remains incompletely understood.

Purpose of the Study:

• To elucidate the link between diabetes, oxidative stress, and associated comorbidities.
• To investigate the impact of diabetes treatments on the Nrf2 antioxidative pathway in target organs.
• To identify the Nrf2 pathway as a potential therapeutic target for diabetic complications.

Main Methods:

• Review of existing literature on diabetes, oxidative stress, and Nrf2 pathway.
• Analysis of how diabetes exacerbates oxidative stress and contributes to organ damage.
• Examination of studies evaluating the effects of antidiabetic treatments on the Nrf2 pathway in cardiac, renal, and hepatic systems.

Main Results:

• Diabetes significantly elevates oxidative stress, driving the pathogenesis of major comorbidities.
• The Nrf2 pathway is demonstrably affected by diabetes and its complications across multiple organ systems.
• Therapeutic interventions for diabetes show parallel modulation of the Nrf2 pathway in the heart, kidney, and liver.

Conclusions:

• The Nrf2 pathway is a common pathogenic factor in diabetes and its associated comorbidities.
• Modulation of the Nrf2 pathway represents a promising therapeutic avenue for managing diabetic complications.
• Further research into Nrf2-targeting agents could lead to novel treatments for diabetes and its sequelae.